NephRx Corp. Initiates Phase I Trial of its Lead Drug Being Developed for ... - PR Newswire (press release) PDF Print
PR Newswire (press release)NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure,

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129